Evidence map›Paper›PMID 41541793›Full record

ArticleComputational and structural biotechnology journal2026

PolyA-GLM: A comprehensive framework for

Sourav Saha, Naima Ahmed Fahmi, Jeongsik Yong, Wei Zhang

Abstract read
In one paragraph

Article in Computational and structural biotechnology journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Sourav SahaDepartment of Computer Science, University of Central Florida, Orlando, FL, USA.
Naima Ahmed FahmiDepartment of Computer Science, University of Central Florida, Orlando, FL, USA.
Jeongsik YongDepartment of Biochemistry, Molecular Biology and Biophysics, University of Minnesota Twin Cities, Minneapolis, MN, USA.
Wei ZhangDepartment of Computer Science, University of Central Florida, Orlando, FL, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Polyadenylation sites (poly(A) sites) play a key role in the post-transcriptional regulation of gene expression. Accurate prediction of poly(A) sites is essential for identifying RNA processing defects associated with cancer and developmental disorders. Traditional approaches based on sequence motifs and experimental validation often struggle to generalize across different cell types and species. To address this limitation, we investigate the use of genome language models (GLMs) for poly(A) site prediction, leveraging their ability to capture long-range dependencies within genomic sequences. Specifically, we evaluate three state-of-the-art GLMs, DNABERT-2, Nucleotide Transformer, and HyenaDNA, using both few-shot classification and fine-tuning strategies. These models effectively recognize canonical polyadenylation signals (PASs) (i.e., AATAAA or other variants) and their spatial relationship (10-30 bp) to cleavage sites, with HyenaDNA achieving an AUC of 0.751 in the few-shot setting and improved performance after fine-tuning. We further validate model interpretability through systematic signal perturbation experiments, confirming their capacity to detect canonical PASs. Additionally, we propose a token-level classification approach for precise position-wise poly(A) site identification across extended gene regions. Finally, we present PolyA-GLM, an end-to-end pipeline for discovering novel poly(A) sites, highlighting the potential of GLMs to reveal regulatory elements overlooked by conventional methods. Overall, this work demonstrates the promise of GLMs in advancing our understanding of RNA processing and regulatory element discovery.

Indexed as

Cross-species testingDe novo polyadenylation site predictionFew-shot learningGenome language modelsPost-transcriptional regulationTransformer models

Identifiers

PMID41541793
PMCPMC12799945

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.